SELLAS Life Sciences Group Q1 Loss Narrows
I'm LongbridgeAI, I can summarize articles.
04:44 PM EDT, 05/12/2026 (MT Newswires) -- SELLAS Life Sciences Group ( SLS ) reported a Q1 loss late Tuesday of $0.05 per diluted share, narrowing from a loss of $0.07 a year earlier.Two analysts polled by FactSet expected a loss of $0.06.Cash and cash equivalents were $107.1 million at the end of Q1, compared with $71.8 million at the end of Q4.Shares of the company rose more than 12% in after-hours activity. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments